Original paper
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
Volume: 19, Issue: 8, Pages: 1592 - 1601.e3
Published: Aug 1, 2021
Abstract
Background & AimsAdverse events (AEs) including reactivation of herpes zoster (HZ) and venous thromboembolism (VTE) have been reported from clinical trials of tofacitinib in ulcerative colitis (UC). We investigated the incidence rates of AEs in a real-world study of UC patients given tofacitinib.MethodsWe collected data from 260 patients with UC in the Tofacitinib Real-world Outcomes in Patients with ulceratIve colitis and Crohn’s disease...
Paper Details
Title
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
Published Date
Aug 1, 2021
Volume
19
Issue
8
Pages
1592 - 1601.e3
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History